Anthera Pharmaceuticals, Inc. (ANTH)
OTCMKTS: ANTH · Delayed Price · USD
0.0001
0.00 (0.00%)
Aug 29, 2024, 4:00 PM EDT - Market closed
Anthera Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 2008 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '18 Mar 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | 2012 - 2008 |
| Cash & Equivalents | 8.09 | 2.2 | 20.84 | 46.95 | 2.64 | 25.95 | Upgrade
|
| Cash & Short-Term Investments | 8.09 | 2.2 | 20.84 | 46.95 | 2.64 | 25.95 | Upgrade
|
| Cash Growth | -60.85% | -89.46% | -55.61% | 1679.12% | -89.83% | 4.82% | Upgrade
|
| Accounts Receivable | - | - | - | 0.33 | - | - | Upgrade
|
| Receivables | - | - | - | 0.33 | - | - | Upgrade
|
| Prepaid Expenses | 0.65 | 1 | 1.87 | 0.59 | 0.38 | 0.36 | Upgrade
|
| Total Current Assets | 8.74 | 3.19 | 22.71 | 47.86 | 3.02 | 26.3 | Upgrade
|
| Property, Plant & Equipment | 0.07 | 0.48 | 0.76 | 0.26 | 0.47 | 0.81 | Upgrade
|
| Other Long-Term Assets | - | - | - | - | - | 10.3 | Upgrade
|
| Total Assets | 8.81 | 3.67 | 23.47 | 48.13 | 3.49 | 37.42 | Upgrade
|
| Accounts Payable | 1.85 | 1.83 | 4.78 | 5.26 | 2.23 | 3.52 | Upgrade
|
| Accrued Expenses | 0.8 | 2.88 | 5.84 | 3.07 | 2.52 | 1.27 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | - | 2.78 | Upgrade
|
| Current Unearned Revenue | - | - | - | 0.14 | - | - | Upgrade
|
| Other Current Liabilities | - | - | - | - | 1 | - | Upgrade
|
| Total Current Liabilities | 2.65 | 4.71 | 10.62 | 8.47 | 5.75 | 7.56 | Upgrade
|
| Long-Term Debt | - | - | - | - | - | 15.1 | Upgrade
|
| Other Long-Term Liabilities | 0.7 | 4.46 | - | - | - | - | Upgrade
|
| Total Liabilities | 3.35 | 9.17 | 10.62 | 8.47 | 5.75 | 22.66 | Upgrade
|
| Common Stock | 0.03 | 0.01 | 0.01 | 0.04 | 0.02 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 447.59 | 428.59 | 411.4 | 391.65 | 314.53 | 301.95 | Upgrade
|
| Retained Earnings | -442.15 | -434.43 | -407.55 | -352.03 | -316.81 | -287.21 | Upgrade
|
| Total Common Equity | 5.46 | -5.83 | 3.86 | 39.66 | -2.26 | 14.76 | Upgrade
|
| Shareholders' Equity | 5.46 | -5.5 | 12.85 | 39.66 | -2.26 | 14.76 | Upgrade
|
| Total Liabilities & Equity | 8.81 | 3.67 | 23.47 | 48.13 | 3.49 | 37.42 | Upgrade
|
| Total Debt | - | - | - | - | - | 17.88 | Upgrade
|
| Net Cash (Debt) | 8.09 | 2.2 | 20.84 | 46.95 | 2.64 | 8.07 | Upgrade
|
| Net Cash Growth | -60.85% | -89.46% | -55.61% | 1679.12% | -67.30% | 92.03% | Upgrade
|
| Net Cash Per Share | 0.57 | 0.21 | 4.04 | 10.54 | 0.97 | 3.53 | Upgrade
|
| Filing Date Shares Outstanding | 26.18 | 23.4 | 5.75 | 5 | 3.64 | 2.5 | Upgrade
|
| Total Common Shares Outstanding | 26.18 | 13.85 | 5.75 | 5 | 2.88 | 2.43 | Upgrade
|
| Working Capital | 6.09 | -1.52 | 12.08 | 39.39 | -2.73 | 18.74 | Upgrade
|
| Book Value Per Share | 0.21 | -0.42 | 0.67 | 7.93 | -0.79 | 6.08 | Upgrade
|
| Tangible Book Value | 5.46 | -5.83 | 3.86 | 39.66 | -2.26 | 14.76 | Upgrade
|
| Tangible Book Value Per Share | 0.21 | -0.42 | 0.67 | 7.93 | -0.79 | 6.08 | Upgrade
|
| Machinery | - | 2.13 | 2.27 | 1.5 | 1.42 | 1.42 | Upgrade
|
| Leasehold Improvements | - | 0.21 | 0.21 | 0.21 | 0.21 | 0.21 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.